PDX Model Market
The PDX model market is projected to reach USD 403 million by 2028 growing at a CAGR of 16.1% over the forecast period (2021-2028).
The factors driving the growth of PDX Model Market includes increasing number of chronic diseases such as cancer, growing investments on research and development in the Cancer Research facilities by private players and growing demand for humanized PDX Models across the world. As per the report published by American Cancer Society, during 2021, around 1.9 million people were diagnosed with cancer in United States, out of which 608,570 cancer patients died in the same year, which can expand the PDX Model Market size in the coming years. Moreover, the increasing burden of cancer patients on the healthcare sector and growing adoption of vitro and in vivo strategies, are some of the additional factors propelling the market growth. In addition, the increasing use of PDX Models for treating Pancreatic cancer, Lung cancer, Brain Tumor and Ovarian cancer, have augmented the growth of PDX Model Market across the globe.
Request For a FREE Sample Report on PDX Model Market
The growth of PDX Model Market is hindered due to high cost of personalized medicines and requirement of expensive drugs.
The prominent players operating in the market are Envigo, Pharmatest Services, Hera Biolabs., JSR Corporation., WuXi AppTec, Charles River Laboratories., Oncodesign, EPO Berlin-Buch GmbH, Xentech, Oncodesign and THE JACKSON LABORATORY among others.
Tumor type – Segment Analysis
As per PDX Model Market Global Forecast, the Respiratory Tumor Models segment is predicted to expand at significant CAGR over the forecast period owing to increasing number of cancer cases and rising development in new products to treat cancer. According to World Health Organization (WHO), around 10 million deaths were recorded in 2020 due to cancer.
Application – Segment Analysis
Based on application, the basic cancer research segment is predicted to lead market during the forecast period attributed to the adoption of PDX Model for cancer research and rising numbers of clinical test across the world.
Regional – Segment Analysis:
Based on region, the North American region is anticipated to grow at healthy CAGR over the forecast period. The increasing demand for personalized medicines, growing investments in the cancer research centers by private players and preclinical activities by pharmaceutical companies, are some of the factors supplementing the market growth in North American region.
Market Segmentation
Global PDX Model Market by Type
- Mice Models
- Rat Models
Global PDX Model Market by Tumor type
- Gastrointestinal Tumor Models
- Gynecological Tumor Models
- Respiratory Tumor Models
- Urological Tumor Models
- Hematological Tumor Models
- Others
Global PDX Model Market by Application
- Preclinical Drug Development
- Biomarker Analysis
- Basic Cancer Research
Global PDX Model Market by End-user
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations (CROs)
- Academic & Research Institutions
Global PDX Model Market by Region
- Asia Pacific
- China
- Japan
- India
- Rest of APAC
- North America
- United States of America
- Canada
- Europe
- United Kingdom
- Germany
- France
- Spain
- Rest of Europe
- RoW
- Brazil
- South Africa
- Saudi Arabia
- UAE
About GMI Research
GMI Research is a market research and consulting firm which provides market insights and intelligence across 12 major sectors helping our clients in making effective investment and business decisions.
Media Contact
Company Name: GMI RESEARCH
Contact Person: Sarah Nash
Email: enquiry@gmiresearch.com
Phone: Europe – +353 1 442 8820; US – +1 860 881 2270
Address: Dublin, Ireland
Website: www.gmiresearch.com
